Literature DB >> 23415079

A generic telemedicine infrastructure for monitoring an artificial pancreas trial.

Davide Capozzi1, Giordano Lanzola.   

Abstract

Telemedicine systems are seen as a possible solution for the remote monitoring of physiological parameters and can be particularly useful for chronic patients treated at home. Implementing those systems however has always required spending a great effort on the underlying infrastructure instead of focusing on the application cores as perceived by their users. This paper proposes an abstract unifying infrastructure for telemedicine services which is loosely based on the multi-agent paradigm. It provides the capability of transferring to the clinic any remotely acquired information, and possibly sending back updates to the patient. The infrastructure is a layered one, with the bottom layer acting at the data level and implemented in terms of a software library targeting a wide set of hardware devices. On top of this infrastructure several services can be written shaping the functionality of the telemedicine application while at the highest level, adhering to a simple agent model, it is possible to reuse those functional components porting the application to different platforms. The infrastructure has been successfully used for implementing a telemonitoring service for a randomized controlled study aimed at testing the effectiveness of the artificial pancreas as a treatment within the AP@home project funded by the European Union.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23415079     DOI: 10.1016/j.cmpb.2013.01.011

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  9 in total

1.  Designing an artificial pancreas architecture: the AP@home experience.

Authors:  Giordano Lanzola; Chiara Toffanin; Federico Di Palma; Simone Del Favero; Lalo Magni; Riccardo Bellazzi
Journal:  Med Biol Eng Comput       Date:  2014-11-28       Impact factor: 2.602

Review 2.  Trends on integrating framework of applications or data. Findings from the section on health and clinical management.

Authors:  N Bricon-Souf; E Conchon
Journal:  Yearb Med Inform       Date:  2014-08-15

3.  DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials.

Authors:  Jérôme Place; Antoine Robert; Najib Ben Brahim; Patrick Keith-Hynes; Anne Farret; Marie-Josée Pelletier; Bruce Buckingham; Marc Breton; Boris Kovatchev; Eric Renard
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

Review 4.  A Digital Ecosystem of Diabetes Data and Technology: Services, Systems, and Tools Enabled by Wearables, Sensors, and Apps.

Authors:  Nathaniel D Heintzman
Journal:  J Diabetes Sci Technol       Date:  2015-12-20

5.  Health-Enabling and Ambient Assistive Technologies: Past, Present, Future.

Authors:  R Haux; S Koch; N H Lovell; M Marschollek; N Nakashima; K-H Wolf
Journal:  Yearb Med Inform       Date:  2016-06-30

6.  Monitoring Artificial Pancreas Trials Through Agent-based Technologies: A Case Report.

Authors:  Giordano Lanzola; Stefania Scarpellini; Federico Di Palma; Chiara Toffanin; Simone Del Favero; Lalo Magni; Riccardo Bellazzi
Journal:  J Diabetes Sci Technol       Date:  2014-03-02

7.  Assessment of Patient Perceptions About Web Telemonitoring Applied to Artificial Pancreas Use at Home.

Authors:  Jérôme Place; Anne Farret; Simone Del Favero; Daniela Bruttomesso; Eric Renard
Journal:  J Diabetes Sci Technol       Date:  2014-03-02

Review 8.  Remote Blood Glucose Monitoring in mHealth Scenarios: A Review.

Authors:  Giordano Lanzola; Eleonora Losiouk; Simone Del Favero; Andrea Facchinetti; Alfonso Galderisi; Silvana Quaglini; Lalo Magni; Claudio Cobelli
Journal:  Sensors (Basel)       Date:  2016-11-24       Impact factor: 3.576

9.  Formulating Telemedicine Strategies in Isfahan University of Medical Sciences.

Authors:  Asghar Ehteshami; Sakineh Saghaeiannejad-Isfahani; Mahnaz Samadbeik; Khdijeh Falah
Journal:  Acta Inform Med       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.